HIV and Hepatitis screening for A&E patients
Patients at emergency departments at Cambridgeshire hospitals will be screened for HIV, hepatitis B and hepatitis C under new plans.
The move comes after the NHS outlined ambitions to end new HIV cases in England by 2030.
The NHS launched a national blood-borne virus (BBV) opt-out testing programme in April 2022 to allow testing in local areas where those infections had a high prevalence.
Peterborough City Hospital (PCH) and Hinchingbrooke Hospital in Huntingdon, run by Northwest Anglia Foundation NHS Trust, have now joined the scheme.
The NHS has confirmed it was extending the program to almost 90 Accident and Emergency (A&E) units in England, following the government 's £27m rollout to 30 new hospitals.
The government said the changes could lead to an extra 1,900 people receiving earlier care for HIV each year.
At PCH and Hinchingbrooke, patients aged 18 and over who attend the emergency department will have a blood test as part of the care.
The BBV testing is an opt-out test, meaning every blood test will automatically be screened for these viruses, unless a patient tells staff not to test their sample.
All tests and results are confidential, with patients only being contacted further if a "non-negative" result is shown.
If patients are not required to have a blood test during their visit, they will not be tested.
Follow Peterborough news on BBC Sounds, Facebook, Instagram and X.
NHS to expand opt-out HIV and hepatitis testing
HIV-positive man welcomes A&E blood testing
A&E patients to be tested for HIV and hepatitis
North West Anglia Foundation NHS Trust
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
WH budget chief pressed on PEPFAR funds, says Africa ‘needs to absorb more of the burden'
Office and Management Budget Director Russell Vought on Wednesday was pressed on proposed cuts to the President's Emergency Plan for AIDS Relief (PEPFAR) pursued as part of a new rescissions request from the Trump administration. During a budget hearing Wednesday, Vought defended proposed reductions as targeting items like 'teaching young children how to make environmentally friendly reproductive health decisions' and efforts he claimed were aimed at strengthening 'the resilience of lesbian, gay, bisexual, transgender, intersex and queer global movements.' 'We can find waste, fraud and abuse there that the American people would not support, and it's one of the reasons why it's in the package, but it will not lead to life saving treatment being denied,' he said during the hearing. Congress, under the Biden administration, appropriated approximately $7 billion for PEPFAR in fiscal 2024. The program is considered to be one of America's most consequential programs in Africa and is credited with saving 25 million lives and scaling back the AIDS epidemic. During the hearing, Rep. Mark Alford (R-Mo.) in a follow-up question pressed Vought again about his comments and potential cuts to prevention efforts. 'Aside from the crazy woke programs, which I agree should be stripped,' Alford asked, 'is there any other prevention program, not treatment, but prevention program listed in this rescission package, which is not of a woke nature?' Vought said in response that the administration seeks to scale 'down the program as it pertains to the types of organizations that are providing the examples of the waste, fraud and abuse.' But he also said 'the prevention itself is where an analytical look needs to be done.' 'There's life saving treatment after you already have HIV, but there are prevention programs that PEPFAR does, which are not of the woke nature, which can prevent someone from getting HIV,' Alford countered. 'Are those programs going to survive?' 'It is something that our budget will be very trim on because we believe that many of these nonprofits are not geared toward the viewpoints of the administration, and we're $37 trillion in debt,' Vought responded. 'So, at some point, the continent of Africa needs to absorb more of the burden of providing this health care.' The moment comes as the prospect of PEPFAR cuts has prompted concern from some congressional Republicans as part of a larger request sent by the Trump administration to cut more than $9 billion in congressionally approved funds for foreign aid and public broadcasting programs. Senate Appropriations Committee Chair Susan Collins (R-Maine) has also voiced opposition to cutting PEPFAR, saying Wednesday that the idea makes 'no sense' to her 'whatsoever.' 'Given the extraordinary record of PEPFAR in saving lives, it has literally saved millions of lives, and so I do not see a basis for cutting it,' she said. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
2 hours ago
- Yahoo
Local Pride center: ‘We need to move from pride flags to policy change'
SAVANNAH, Ga. (WSAV)– The Savannah Pride Center offers year-round therapy, support groups and help with medical care for their community. The center's executive director Micheal Bell told WSAV that pride is all about becoming stronger as a community but he said this year there is more work than ever. 'We have the fastest growing new HIV cases in the country,' Bell said. 'We are one of the lowest in health care and we have a huge, vibrant, diverse LGBTQ+ population. The work is there to do but we also have to remember to celebrate that diversity.' Recently the Savannah Pride Center announced a new partnership with the Savannah Police Department. The police and the center developed a relationship after one of the Savannah Pride Center volunteers was murdered. 'With the police department, we have an opportunity to train the police on pronouns, history and culture with the LGBTQ+ community,' Bell Said 'This is the biggest step forward that our community has taken to protect our LGBTQ+ community here in Savannah.' The Savannah Pride Center will host an event on June 28 at Starland Yard to honor the history of the Stonewall Uprising. They emphasize that pride is ultimately about coming together and being stronger as a community. The city of Savannah recognizes June and October as Pride Months due to June being the start of hurricane season. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Newsweek
3 hours ago
- Newsweek
I Went for a Routine Blood Test at 21—What Came Next Changed My Life
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Perhaps the last thing that Ellie Harrison, now 28, expected to be told by nurses after using a routine at-home STD testing kit was that she had HIV. Harrison, who was 21 at the time, showed neither signs nor symptoms related to the virus, and was in a long-term relationship. Young and carefree, Harrison had rarely given her health a second thought, and was "shocked" to learn that she had contracted HIV without even knowing. While the result may have upended her personal life and made dating "a minefield," it has also transformed her into one of the the U.K.'s most visible young HIV activists. Harrison says that although her social life has become much more complex, her diagnosis has empowered her to speak out about the virus and the misconceptions around it. From left: Ellie Harrison smiles while sitting at a restaurant dining table; and takes a mirror selfie in her bathroom. From left: Ellie Harrison smiles while sitting at a restaurant dining table; and takes a mirror selfie in her bathroom. @elliestayingpositive "I suffered with a lot of self-stigma in the early days due to my lack of understanding of the virus," Harrison, who is based in Manchester, England, told Newsweek. "I now refer to my diagnosis as one of the best things that could have happened to me. "I've been able to ignite a passion for public speaking and activism, which I don't think I would have otherwise found." Over the past seven years, Harrison has reframed her diagnosis from a setback to a calling. She began publicly sharing her story under the handle @elliestayingpositiveonline, where she uses social media platforms to break down misconceptions about HIV, discusses medical facts, and speaks frankly about relationships and self-image. But while Harrison has found purpose in her activism, dating has been a more challenging arena. She has remained single since her diagnosis, a decision shaped less by choice than by the reactions she sometimes encounters. "Dating with HIV has always been a bit of a minefield," she said. "You can never judge what people's reactions are going to be like, and how that could make me feel." Although she has learned to be open and informative in her interactions, Harrison says many heterosexual people still know very little about HIV. This knowledge gap is often filled with fear, judgment, or outdated assumptions—particularly when it comes to women. HIV, or human immunodeficiency virus, is a virus that attacks the body's immune system. If left untreated, it can lead to acquired immunodeficiency syndrome (AIDS), the most severe phase of the infection. Unlike some other viruses, the human body cannot get rid of HIV completely, but it can be controlled with proper medical care. Living With HIV "In the early days of my diagnosis I struggled with a lot of stigma, often met with confusion that a young woman could have contracted a virus, and it often led to questions around promiscuity," she said. "Unfortunately, I don't think the stigma has moved along much since the 1980s, especially within the heterosexual community." Harrison now works to combat that stigma by educating others about the realities of modern HIV treatment and prevention. A key message is U=U: undetectable equals untransmittable. This means that people who are on effective antiretroviral therapy and maintain an undetectable viral load cannot pass the virus on. "For me, I think it's important we educate everyone about the advancement of HIV medication," she said. "Removing this fear will hopefully make it easier for people living with HIV to talk more freely around their status. "An HIV diagnosis isn't the end, it is just the start of a new beginning." Alongside fighting misinformation, Harrison hopes to shine a light on another overlooked issue: the low rates of HIV testing and prevention among women in the U.K. In 2023, women accounted for 44 percent of new HIV diagnoses globally—but women represented only 3.1percent of people attending specialist sexual health services who initiated or continued use of PrEP in England in 2023. PrEP is a drug taken by HIV-negative people that prevents HIV infections. "We should talk more about the lower uptake in women taking HIV tests, or HIV prevention treatments," Harrison said. "Sex is often quite the taboo subject, which I think goes hand in hand with women having a strong aversion to going to STI clinics or testing in general." Harrison believes some of the blame lies with healthcare providers, who may not consider women at risk and therefore fail to offer them appropriate testing or prevention options. That lack of engagement leads to later diagnoses, which can have serious health consequences. She also pointed out that many women who are diagnosed with HIV feel pressure to keep their status a secret by brushing it under the carpet. She wants to change that by modeling a life not of shame or fear, but of achievement, fulfillment and happiness. "I'd like to use my voice to show women that there is nothing to hide or be ashamed of following a HIV diagnosis," she said. "I may have been single since the day I was diagnosed with HIV at 21, but I have also graduated from university with a first-class degree. "I have developed a very successful career and as an HIV activist have been offered incredible opportunities." Her accomplishments are not limited to her professional and activist work, as Harrison has also maintained a "wonderful" relationship with her parents, who have supported her throughout her journey. "I've also started living alone, met some incredible friends, and for the most part I've been really happy," she added. Harrison gained more viral attention on TikTok in April, after poking fun at her diagnosis in a lighthearted manner. The short clip has racked up 1.1 million views to date. She said she has been "blown away by all the support" and welcomes honest dialogue, even if it occasionally includes harsh opinions. "There's always going to be people who have harsh feelings around dating someone with HIV," she said. "But I often find they aren't the type of people I'd get on with much anyway, so it's not much of a loss." New Hope for HIV What drives her now is creating a world where young people, particularly young women, feel confident enough to take an HIV test and informed enough to live openly and fully with a diagnosis—knowing that it does not need to define them. "I absolutely love seeing other young people living with HIV speaking out," she said. "It's important to me that the media works to represent all different types of people living with HIV, whether that be sexuality, gender or race. "I think it's important to normalize HIV in the same way as other medical conditions, because if treated correctly, it can't be passed on and does not need to be a huge part of your life." In January, infectious disease experts spoke with Newsweek about HIV treatments and a potential vaccine on the horizon. Molecular virologist Jonathan Ball, deputy vice chancellor at the U.K.'s Liverpool School of Tropical Medicine, told Newsweek: "The major advances have been in simplified and/or long-lasting antiretroviral regimens, which can also be used to prevent infection." Antiretroviral medicines work by preventing the virus from replicating in the body, allowing the immune system to repair itself and preventing further damage. People who use antiretroviral medications can reduce the viral load of HIV in the body to undetectable levels, which can stop them from passing it to others. The 2024 breakthrough of the year, according to the journal Science, was with the drug lenacapavir, an antiretroviral medicine that performed very well in scientific trials. Dr. Robert Hopkins Jr., medical director of the National Foundation for Infectious Diseases, told Newsweek: "This fall, a trial was published comparing the drug lenacapavir, injected once every six months, with a daily oral combination pill to prevent HIV infection in women in Africa. "The trial was a tremendous success and showed dramatically lower HIV transmission than with the oral drug," he added. Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration this year, with the potential to dramatically reduce HIV infection. "This will be a critical next step toward stopping HIV transmission, perhaps not in 2025 but hopefully in the near future," he said. Is there a health issue that's worrying you? Let us know via health@ We can ask experts for advice, and your story could be featured on Newsweek.
